May 22, 2026

Sex Disparities May Persist in CF Despite Modulators

Review findings suggested female patients with cystic fibrosis may continue to experience worse pulmonary outcomes despite highly effective modulator therapy

Conexiant

May 13, 2026

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

Conexiant

May 13, 2026

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.

Conexiant

May 13, 2026

Chronotherapy Trial Tests Sleep Timing in Adolescents

Two-week chronotherapy trial evaluates circadian phase, sleep duration, and alignment outcomes.

Conexiant

May 12, 2026

Language Processing Persists Under Anesthesia

Intraoperative recordings suggested preserved processing of speech and auditory context during unconsciousness.

Conexiant

May 11, 2026

New Label Expansion in Generalized Myasthenia Gravis

Phase 3 ADAPT SERON data supported efgartigimod use across antibody subtypes often underrepresented in trials.

Conexiant

May 11, 2026

Bowel Management May Cut Wet Days in Kids

“These findings underscore the importance of adequately treating constipation as a prerequisite for optimizing the effect of standard urotherapy."

Conexiant

May 11, 2026

Health, Social Needs Tied to Absences

National survey data suggest overlapping chronic health and social needs are associated with higher rates of illness-related missed school days among US children.

Conexiant

May 07, 2026

Multimodal Brain Monitoring May Improve ICU Outcomes

Integrated neuromonitoring approaches may help identify neurologic complications earlier in patients admitted to ICU.

Conexiant

May 06, 2026

Symptom Scores May Signal Neuropathy Risk

Early recovery symptom patterns may help clinicians identify which oropharyngeal cancer survivors warrant closer neurologic surveillance.

Conexiant